The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Dandekar Atul

Reporting owner CIK 0002050167 · CSBO

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Dandekar AtulDandekar AtulDandekar Atul · September 29, 2026 · Exercise / conversion · Common StockDandekar Atul · December 30, 2025 · Exercise / conversion · Common StockDandekar Atul · December 29, 2025 · Exercise / conversion · Common StockDec 29, 2025Sep 29, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Sep 29, 2026Maze Therapeutics, Inc.Common StockDandekar AtulExercise / conversion
Dec 30, 2025Maze Therapeutics, Inc.Common StockDandekar AtulExercise / conversion
Dec 29, 2025Maze Therapeutics, Inc.Common StockDandekar AtulExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Maze Therapeutics, Inc.MAZE · company listingsExercise / conversionCommon StockNon-derivative security · Code M7,50010.42Value: 78,150Currency not specifiedView ↗
Trade: Maze Therapeutics, Inc.MAZE · company listingsExercise / conversionCommon StockNon-derivative security · Code M10010.42Value: 1,042Currency not specifiedView ↗
Trade: Maze Therapeutics, Inc.MAZE · company listingsExercise / conversionCommon StockNon-derivative security · Code M72,40010.42Value: 754,408Currency not specifiedView ↗